Year |
Citation |
Score |
2020 |
Liu YA, Jin Q, Ding Q, Hao X, Mo T, Yan S, Zou Y, Huang Z, Zhang X, Gao W, Wu TY, Li C, Bursalaya B, Di Donato M, Zhang YQ, ... ... Kamireddy A, et al. A Dual Inhibitor of DYRK1A and GSK3β for β-Cell Proliferation: Aminopyrazine Derivative GNF4877. Chemmedchem. PMID 32613743 DOI: 10.1002/Cmdc.202000183 |
0.62 |
|
2020 |
Liu YA, Jin Q, Zou Y, Ding Q, Yan S, Wang Z, Hao X, Nguyen B, Zhang X, Pan J, Mo T, Jacobsen K, Lam T, Wu TY, Petrassi HM, ... ... Kamireddy A, et al. Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133. Journal of Medicinal Chemistry. PMID 32077280 DOI: 10.1021/Acs.Jmedchem.9B01624 |
0.598 |
|
2015 |
Shen W, Taylor B, Jin Q, Nguyen-Tran V, Meeusen S, Zhang YQ, Kamireddy A, Swafford A, Powers AF, Walker J, Lamb J, Bursalaya B, DiDonato M, Harb G, Qiu M, et al. Inhibition of DYRK1A and GSK3B induces human β-cell proliferation. Nature Communications. 6: 8372. PMID 26496802 DOI: 10.1038/Ncomms9372 |
0.618 |
|
2013 |
Shen W, Tremblay MS, Deshmukh VA, Wang W, Filippi CM, Harb G, Zhang YQ, Kamireddy A, Baaten JE, Jin Q, Wu T, Swoboda JG, Cho CY, Li J, Laffitte BA, et al. Small-molecule inducer of β cell proliferation identified by high-throughput screening. Journal of the American Chemical Society. 135: 1669-72. PMID 23330637 DOI: 10.1021/Ja309304M |
0.558 |
|
Show low-probability matches. |